Featured
boursenews.ma•Jun 1, 2026
Promopharm Q1 2026 Revenue Slides 1.9% to DH208.2m Amid Hospital Sales Dip
Read More
Market Insights
BOURSSOLE Newsroom
Stay ahead of the market with our curated AI-powered financial news and expert analysis.
2 results for “Moroccan Pharma”
Stocks Market
•December 8th, 2025Moroccan Pharma Sothema Notifies Acquisition of Eli Lilly's Cialis Assets to Competition Council
Sothema, the Moroccan pharmaceutical company, has formally notified the Competition Council of its planned acquisition of certain pharmaceutical assets from the American giant Eli Lilly and Company. The deal specifically targets the brand and products related to CIALIS, a well-known medication used ...
You've reached the end of the list